Research Paper Volume 14, Issue 24 pp 10050—10066
SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination
Figure 1. The levels of SGOL2 expression upregulated in prostate cancer. (A) TCGA analysis showed SGOL2 expression in prostate cancer tissue and adjacent normal tissue. (B) The relationship between SGOL2 expression and the Gleason score of patients. (C) Correlation between SGOL2 expression and nodal metastasis status. (D) Representative IHC images for SGOL2 expression level in prostate cancer tissue microarrays. *, P<0.05; **, P<0.01; ***, P<0.001.